Abeona therapeutics reports full year 2022 financial results and provides corporate update

Expects to submit bla for eb-101 to fda in late-2q/early-3q 2023 based on positive phase 3 viital™ study results announced in 4q 2022
ABEO Ratings Summary
ABEO Quant Ranking